The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">(i) Congestive heart failure</td></tr><tr><td align="left">(ii) Portal vein thrombosis</td></tr><tr><td align="left">(iii) Progressive liver failure</td></tr><tr><td align="left">(iv) Chronic recurrent encephalopathy</td></tr><tr><td align="left">(v) Stent dysfunction</td></tr><tr><td align="left">(vi) “TIPSitis”</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Chronic complications after TIPS placement.

International Journal of Hepatology

tab3

Table 3

Table 3: The Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Current Status 